Biotech

All Articles

Amgen records very first phase 3 gain for $400M dermatitis medicine

.Amgen has actually shared (PDF) the 1st stage 3 data on its $400 thousand dermatitis drug, connecti...

Biogen, UCB report stage 3 lupus win after stopping working earlier trial

.Biogen and also UCB's bank on improving into period 3 astride a broken research hopes to have actua...

Aptadir wishes new RNA preventions can turn around tricky cancers cells

.Italian biotech Aptadir Therapies has actually introduced along with the assurance that its pipelin...

Wave surfs DMD success to regulators' doors, sending stockpile

.Surge Lifestyle Sciences has actually met its own goal in a Duchenne muscular dystrophy (DMD) study...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold...

Achilles splashes cell treatment plan, prepares for cutbacks after missing 'office viability' targets

.Achilles Rehabs has torn up its own method. The British biotech is actually knocking off on its cli...

Aligos heralds stage 2 MASH win, reducing liver excess fat approximately 46%

.Aligos Therapies is advertising a midstage succeed in metabolic-dysfunction linked steatohepatitis ...

Basilea scores $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work establishing new antifungals has acquired a notable boost coming from ...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Having actually scooped up the U.S. civil rights to Capricor Rehabs' late-stage Duchenne muscular d...

FDA fragments adcomm for Applied's uncommon disease drug

.After pushing the selection meeting for Applied Therapeutics' metabolic ailment drug govorestat, th...